Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Hospira, Inc. | 0409-6970 | INTRAMUSCULAR, INTRAVENOUS | 100 mg in 1 mL | 11/17/2022 | |
| Zydus Lifesciences Limited | 70771-1352 | INTRAMUSCULAR, INTRAVENOUS | 20 mg in 1 mL | 10/19/2023 | |
| Lifestar Pharma LLC | 70756-613 | INTRAMUSCULAR, INTRAVENOUS | 20 mg in 1 mL | 2/3/2023 | |
| Amring Pharmaceuticals Inc. | 69918-700 | INTRAMUSCULAR, INTRAVENOUS | 20 mg in 1 mL | 11/22/2022 | |
| Delpharm Boucherville Canada Inc. | 82650-138 | INTRAVENOUS, INTRAMUSCULAR, PARENTERAL | 20 mg in 1 mL | 3/13/2024 | |
| Somerset Therapeutics, LLC | 70069-301 | INTRAMUSCULAR, INTRAVENOUS | 20 mg in 1 mL | 7/6/2023 | |
| Medical Purchasing Solutions, LLC | 71872-7166 | INTRAMUSCULAR, INTRAVENOUS | 20 mg in 1 mL | 5/15/2023 | |
| Somerset Therapeutics, LLC | 70069-783 | INTRAMUSCULAR, INTRAVENOUS | 20 mg in 1 mL | 5/27/2023 | |
| Medical Purchasing Solutions, LLC | 71872-7251 | INTRAMUSCULAR, INTRAVENOUS | 20 mg in 1 mL | 4/27/2023 | |
| Piramal Critical Care Inc | 66794-232 | INTRAVENOUS, INTRAMUSCULAR | 20 mg in 1 mL | 12/21/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| QUELICIN INJ 20MG/ML USP | ABBOTT LABORATORIES, LIMITED | 00640778 | Solution - Intramuscular
,
Intravenous | 20 MG / ML | 12/31/1985 |
| QUELICIN | 00038172 | Solution - Intravenous | 20 MG / ML | 12/31/1952 | |
| ANECTINE INJ 20MG/ML | glaxo wellcome inc. | 00268305 | Liquid - Intravenous | 20 MG / ML | 12/31/1952 |
| SUCCINYLCHOLINE CHLORIDE INJECTION, USP | dr reddy's laboratories ltd | 02501783 | Solution - Intravenous | 20 MG / ML | 9/29/2020 |
| SUCCINYLCHOLINE CHLORIDE INJECTION USP | hikma canada limited | 02422336 | Solution - Intravenous | 20 MG / ML | 9/30/2014 |
| QUELICIN | 00296163 | Solution - Intravenous | 100 MG / ML | 12/31/1976 | |
| SUCCINYLCHOLINE CHLORIDE INJECTION, USP 20MG/ML | alveda pharmaceuticals inc | 02300419 | Liquid - Intravenous | 20 MG / ML | 9/13/2012 |
| ANECTINE FLOPACK 500MG | glaxo wellcome inc. | 00068330 | Powder For Solution - Intravenous | 500 MG / PCK | 12/31/1959 |
| SUCCINYLCHOLINE CHLORIDE INJECTION USP | Mylan Pharmaceuticals ULC | 02062232 | Solution - Intravenous | 20 MG / ML | 11/12/1996 |
| QUELICIN CHLORIDE INJ 100MG/ML | ABBOTT LABORATORIES, LIMITED | 00296163 | Solution - Intravenous | 100 MG / ML | 12/31/1983 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.